Intra-Articular Bone Marrow Aspirate Concentrate Injection in Patients with Knee Osteoarthritis

Autor: Jae Do Kim, Gi Beom Kim, Chang Hyun Choi, Gun Woo Lee, Young Sang Choi
Rok vydání: 2020
Předmět:
musculoskeletal diseases
medicine.medical_specialty
Visual analogue scale
knee
Osteoarthritis
Knee Joint
lcsh:Technology
lcsh:Chemistry
03 medical and health sciences
0302 clinical medicine
Bone marrow aspirate
Primary outcome
Intra articular
bone marrow aspirate concentrate
medicine
General Materials Science
In patient
lcsh:QH301-705.5
Instrumentation
030203 arthritis & rheumatology
Fluid Flow and Transfer Processes
030222 orthopedics
lcsh:T
business.industry
Process Chemistry and Technology
General Engineering
musculoskeletal system
medicine.disease
clinical outcomes
lcsh:QC1-999
Computer Science Applications
Surgery
osteoarthritis
lcsh:Biology (General)
lcsh:QD1-999
lcsh:TA1-2040
lcsh:Engineering (General). Civil engineering (General)
business
Tegner Activity Scale
human activities
lcsh:Physics
Zdroj: Applied Sciences, Vol 10, Iss 5945, p 5945 (2020)
Applied Sciences
Volume 10
Issue 17
ISSN: 2076-3417
DOI: 10.3390/app10175945
Popis: We aimed to evaluate the 5-year follow-up outcomes of an intra-articular bone marrow aspirate concentrate (BMAC) injection in patients with knee osteoarthritis. This is the first study to report the outcomes following BMAC injections over a 5-year follow-up period. Seventy knees of 37 patients, including 33 bilateral knees, were investigated. The primary outcome was the visual analogue scale (VAS) score for pain in the knee joint, and the secondary outcomes were the International Knee Documentation Committee score, the 36-Item Short Form Health Survey score, the Knee injury Osteoarthritis Outcome Score, Lysholm Knee Questionnaire/Tegner activity scale, BMAC injection-induced complications, and 5-year treatment success rate. The 5-year post-injection VAS scores (4.7 ±
0.5) were significantly lower than the preoperative scores (8.3 ±
1.2) (p = 0.01). Improvement in VAS scores was significantly greater in patients with Kellgren&ndash
Lawrence (K-L) Grade I or II than those in those with K-L Grade III or IV. Improvement in other clinical parameters and success rates were significantly low and the rates of secondary operation and failure were significantly higher in patients with K-L Grades III or IV. Intra-articular BMAC injections could be useful for managing patients with K-L Grades I or II osteoarthritis.
Databáze: OpenAIRE